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Pan masala, a dry powdered mixture of areca nut, catechu,
lime, unspecified spices and flavoring agents, has gained
widespread popularity as a chewing substitute in India. In this
study, the carcinogenic and tumor-promoting potential of an
ethanolic pan masala extract (EPME) was determined using
skin of S/RVCri-ba mice and forestomach and esophagus of
ICRC mice as the target tissues. Carcinogenic activity of pan
masala was tested by painting the mouse skin for 40 weeks
with EPME or by gavage feeding for 6 months. Following
initiation with 9,10-dimethylbenz(a)anthracene (DMBA), car-
cinogenesis of mouse skin was promoted with different doses
of EPME, while gastric- and esophageal-tumor-promoting
activity was determined by administering EPME by gavage to
animals initiated with diethylnitrosamine (DEN). The ability
of EPME to effect progression of skin papilloma to carcinoma
and cutaneous alterations after a single or multiple EPME
treatment were also evaluated. EPME at 25 mg per dose
promoted skin-papilloma formation between 30 and 40 weeks
of treatment and enhanced the rate of conversion of papil-
loma to carcinoma. Induction of mild epidermal hyperplasia,
dermal edema, increase in epidermal mitotic activity and the
rate of epidermal and dermal DNA synthesis by EPME
correlated well with its skin-tumor-promoting potential. In
ICRC mice, EPME was inactive as a complete carcinogen, but
effectively promoted the development of forestomach and
esophageal papilloma and carcinoma in a concentration-
dependent manner. The tumor incidence at 25 mg EPME per
dose was comparable with that obtained in the 12-0-tetrade-
canoylphorbol-13 acetate(TPA)-treated group. The findings
indicate that habitual pan-masala use may exert carcinogenic
and co-carcinogenic influence. Int. J. Cancer 75:225–232, 1998.
r 1998 Wiley-Liss, Inc.
Habitual chewing of betel quid, locally called ‘‘pan,’’ is widely
prevalent in India since ancient times. A pan is prepared by
smearing the betel leaf with lime and catechu; pieces of areca nut
and desirable spices such as cardamom and cloves, are placed on
the leaf, which is folded into an ornate shape. In the last two
decades, the Indian market has been flooded with a powdered
chewing mixture containing the main dry ingredients of betel quid,
menthol, unspecified spices and flavoring agents. This chewing
product, termed ‘‘pan masala,’’ has gained widespread popularity
and social acceptance in several Asian countries, particularly
among women and children who generally refrain from using
tobacco in any form.
Areca nut, the major constituent of pan masala, has been found
to exhibit clastogenic, genotoxic and carcinogenic potential in
different experimental systems (Suri et al., 1971; Ranadive et al.,
1976; IARC, 1985; Panigrahi and Rao, 1986; Sundqvist et al.,
1989; Dave et al., 1992). Catechu was shown to cause dominant
lethal mutation and chromosomal damage in mouse bone-marrow
cells (Giri et al., 1987), while lime is reported to induce irritation as
well as hyperplasia of the oral mucosa (Dunham et al., 1966; Sirsat
and Kandarkar, 1968) and produce reactive oxygen species in
combination with catechin fraction of areca nut in vitro (Nair et al.,
1992). Epidemiological studies have shown an association between
the habit of chewing betel nut and high risk for oral cancer in the
Indian population in South Africa and Malaysia (Schonland and
Bradshaw, 1969; Chin and Lee, 1970).
In keeping with the genotoxic properties of the individual
constituents, an extract of pan masala was found to increase the
frequencies of sister chromatid exchanges and chromosomal aber-
rations in mouse bone-marrow cells (Mukherjee and Giri, 1991)
and Chinese hamster ovary cells (Adhvaryu et al., 1989). Muta-
genic potential of ethanolic (Bagwe et al., 1990) and aqueous
extracts (Polasa et al., 1993) of different brands of pan masala has
also been reported. However, no information exists regarding the
neoplastic potential of pan masala. In the present study, we
investigated the carcinogenic and tumor-promoting activity of pan
masala in 2 mouse models, using skin, esophagus and forestomach
as the target tissues. The effect of pan masala on cutaneous
alterations including epidermal hyperplasia, cell proliferation and
inflammation considered to be crucial for mouse skin-tumor
promotion (Argyris, 1985) was also evaluated.
MATERIAL AND METHODS
Chemicals
DMBA, DEN and TPA were purchased from Sigma (St. Louis,
MO (3H) methyl thymidine (specific activity 18000 mCi /mmol)
was obtained from BRIT (Mumbai, India). The choice of the pan
masala brand was based on the results of a market survey
conducted at different locations in Mumbai, India. The brand with
the highest sale, which we employed in the present study, was
identical to the one used by us in mutagenicity experiments earlier
(Bagwe et al., 1990). In order to avoid possible batch-to-batch
variation in chemical constituents, bulk quantities of the same
batch were purchased and stored at 220°C until use. All other
chemicals were of analytical grade.
Preparation of ethanolic pan-masala extract (EPME)
Finely powdered pan masala was mixed with 5 vol of redistilled
ethanol and the contents were extracted by agitation on a rotary
shaker for 24 hr at room temperature. The supernatant collected
after centrifugation at 12050 g was evaporated to dryness by flash
evaporation. The dry residue was dissolved in a minimal amount of
redistilled ethanol and further in 100 µl of acetone or distilled water
(DW) to obtain EPME doses equivalent to 12.5, 25 and 50 mg of
original pan masala powder.
Animals and treatments
An inbred hairless mouse strain obtained from the Animal house
of the Cancer Research Institute, Mumbai, India, designated
S/RVCri-ba or ‘‘Bare’’ was used for skin tumorigenesis experi-
ments. Female Bare mice 6- to 7-week-old were randomly divided
into 11 groups of 15 each for carcinogenicity studies (Table I) and 8
groups of 5 each for histomorphometric analysis (Table II). For
determining gastric and esophageal tumorigenesis, 6- to 8-week-
old inbred male and female mice (30 per group, 15 of each sex) of
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ICRC/HiCri (ICRC) strain (Randelia et al., 1988) were used.
Animals of the same sex were housed 5 to a cage in an
air-conditioned animal house (temperature 21 6 1°C; humidity
55-60%; constant 12-hr light/dark cycle) and were provided with
pelleted mouse feed and water ad libitum. Different doses of EPME
and TPA or 20 nmol DMBA were dissolved in 100 µl acetone and
applied topically using a micropipette to the back skin of Bare
mice, while 100 µl aqueous solutions of EPME and TPA were
administered by gavage to ICRC mice.
Complete carcinogenesis. The back skin of uninitiated S/
RVCri-ba mice was treated twice a week with acetone or 25 and 50
mg EPME in acetone for 40 weeks. Groups of ICRC mice received
by gavage the same doses of EPME in DW or DW only, 5 times a
week for 6 months.
Tumor initiation. S/RVCri-ba mice were initiated with a single
topical application of 25 mg EPME or acetone followed one week
later by twice-weekly treatment with 1.8 nmol TPA in 100 µl of
acetone for a period of 40 weeks. However, the ability of EPME to
initiate gastric or esophageal tumors was not evaluated.
Tumor promotion and progression. Skin-tumor-promoting activ-
ity of EPME was determined in Bare mice initiated with 20 nmol of
DMBA in 100 µl of acetone. One week after initiation, mice
received twice-weekly applications of 12.5, 25 or 50 mg of EPME
for 40 weeks. In experiments on the progression of skin papilloma
to carcinoma, papillomas were induced by the standard DMBA-
TPA protocol (Boutwell, 1974). After a treatment-free period of 6
weeks, the back skin was treated with acetone or 25 mg EPME for
14 weeks. To evaluate the tumor-promoting activity of EPME in
the forestomach and esophagus, ICRC mice were initiated with a
cumulative DEN dose of 16 mg/kg body weight administered in
drinking water for 4 days. This dose of DEN was chosen on the
basis of preliminary experiments wherein cumulative DEN doses
ranging from 16 mg to 225 mg/kg body weight were given in
drinking water for a period of 4 days to 8 weeks to determine the
initiating dose of DEN (data not shown). Since no gross tumors
were observed either in the esophagus or in the forestomach of
ICRC mice killed 6 months after 4 days treatment with a
cumulative dose of 16 mg/kg body weight, this dose of DEN was
preferred for tumor initiation. One week later, mice were gavage-
fed DW or 12.5-, 25- and 50-mg doses of EPME, 5 days a week for
3 and 6 months. TPA (5 nmol) dissolved in DW was administered
by gavage as a positive control for 3 months.
A monthly record of animal weight and survival rate was
maintained for all the mice. In the Bare mouse strain, the number of
tumors ($1 mm diameter) was recorded every week. Necropsy was
performed on all moribund animals and at the end of the exper-
imental period. Skin and tumor tissues from Bare mice and lung,
liver, stomach, esophagus, kidney, spleen, intestine and urinary
bladder of ICRC mice were fixed in Bouin’s fluid and processed for
routine histopathology. The esophagus was dissected completely
open on a filter paper so that it remained flat, while the stomach was
opened across the greater curvature. The number of tumors was
recorded in the organs and confirmed histopathologically. The
percentage of tumor bearers and the average number of tumors per
mouse in experimental and control groups were compared using
Chi-squared distribution and Student’s t-test respectively.
Histomorphometric analysis
DMBA-initiated Bare mice received a single application or
multiple applications (twice weekly for 40 weeks) of acetone or
12.5-, 25- and 50-mg doses of EPME. Mice were killed 1 hr after
i.p. injection of 10 µCi (3H) methyl thymidine in 0.1 ml of PBS and
48 hr after the last promoter treatment. Skin tissues were excised,
fixed in Bouin’s fluid and processed for routine histopathology.
Additional sections were processed for autoradiography, and
histomorphometric analysis was carried out as described (Bagwe et
al., 1994). Data were analyzed by Cochran-Fisher modification for
analysis of variance and by Student’s t-test for the comparison of
means in control and experimental groups.
RESULTS
Skin tumorigenesis
In all the groups, EPME treatment did not induce overt signs of
toxicity as judged by visual observation of the skin and change in
body weight relative to controls. Multiple applications of 25 or 50
mg EPME to uninitiated Bare mouse skin or a single application of
25 mg EPME as an initiator followed by TPA promotion for 40
weeks failed to induce skin tumors. As compared with controls, a
2-fold increase in the rate of conversion of papilloma to carcinoma
(27% vs. 13%) was observed when 25 mg EPME was applied in the
progression phase. However, the increase was statistically not
significant.
As shown in Table III, the time required for the appearance of the
first tumor was similar in DMBA-initiated mice treated with
acetone or 3 different doses of EPME. The time for tumor
development in 100% of the animals was 32 weeks in the control
group, while it was 39, 29 or 26 weeks in mice treated with 12.5, 25
TABLE I – EXPERIMENTAL DESIGN OF SKIN CARCINOGENESIS IN FEMALE S/RV Cri-ba MICE1
Group Number
of mice Initiation Promotion Progression Purpose
1 15 0.1 ml acetone 0.1 ml acetone — Solvent control for complete
carcinogenesis
2 15 25 mg EPME 25 mg EPME — Complete carcinogenic activity
of EPME
3 15 50 mg EPME 50 mg EPME — Complete carcinogenic activity
of EPME
4 15 0.1 ml acetone 1.8 nmol TPA — Solvent control for tumor ini-
tiation
5 15 25 mg EPME 1.8 nmol TPA — Tumor-initiating activity of
EPME
6 15 20 nmol DMBA 0.1 ml acetone — Solvent control for tumor pro-
motion
7 15 20 nmol DMBA 12.5 mg EPME — Tumor-promoting activity of
EPME
8 15 20 nmol DMBA 25 mg EPME — Tumor-promoting activity of
EPME
9 15 20 nmol DMBA 50 mg EPME — Tumor-promoting activity of
EPME
10 15 20 nmol DMBA 5 nmol TPA 0.1 ml acetone Solvent control for tumor pro-
gression
11 15 20 nmol DMBA 5 nmol TPA 25 mg EPME Tumor progression with EPME
1For details of treatment, see ‘‘Material and Methods’’.
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and 50 mg EPME respectively (Fig. 1). Up to the 30th week of
promotion, no significant changes in tumor yield or rate were
observed between the control and experimental groups. At week
40, however, a dose-dependent increase in papilloma yield was
observed in animals given 12.5- and 25-mg doses of EPME, while
at the highest dose (50 mg) the papilloma yield was similar to that
in animals treated with 12.5 mg EPME (Table III, Fig. 1). At the
dose of 25 mg EPME, the increase in the average number of tumors
per mouse was statistically significant (Table III, p , 0.05).
Histopathologically, the papillomas were well-differentiated hyper-
plastic lesions with excessive keratinization and mild cellular atypia.
Histomorphometric alterations
The morphology of Bare mouse skin after a single application of
acetone following DMBA initiation resembled that of the normal
tissue. Similar treatment with 25 mg EPME resulted in mild
epidermal hyperplasia and dermal edema, as evident from a
significant increase in the epidermal and dermal thickness and the
number of nucleated epidermal cell layers (Table II). Moreover, as
compared with acetone control, a significant increase in epidermal
mitotic activity was observed after a single application of EPME at
all the 3 doses. The number of labelled nuclei per 5 mm surface
length was significantly higher in EPME(25 mg)-treated epidermis
and dermis.
Sustained epidermal hyperplasia and an increase in mitotic
activity in the suprabasal layer, epidermal and dermal thickness, as
well as increased number of labelled cells per 5 mm surface length
in the epidermis and dermis, were also observed in mice treated
with 12.5 or 25 mg EPME for 40 weeks. The increase in these
parameters was statistically significant in the group receiving 25
mg EPME. The number of basal epidermal cells was significantly
lower in this group as compared with the solvent control epidermis
(Table II).
Gastric and esophageal tumorigenesis
Macroscopic observations. The survival rate of ICRC mice in
the control and experimental groups ranged from 86 to 100%, since
a few animals died due to lung infection. At the start of the
experiment, the mean body weight of male and female mice was 34
g and 30 g respectively. Generally, the animals gained body weight
during the first 3 months of treatment. However, weight loss of 2 to
3 g was observed in animals receiving EPME for 6 months. On
gross observations, raised or nodular surfaces as well as papillomas
were noted in the forestomach and esophagus of animals treated
with EPME. The papillomas were generally located near the
limiting ridge in the forestomach. No gross abnormalities were
observed in lung, liver, spleen, kidney or intestine. The incidence
and multiplicity of tumors in the forestomach and esophagus in
males and females as well as cumulative rate and yield are
summarized in Tables IV and V respectively.
Complete carcinogenic activity of EPME. Administration of
EPME to uninitiated ICRC mice for 6 months did not induce
forestomach or esophageal tumors.
Tumor promoting activity of EPME
Forestomach tumors. The overall rate and yield of forestomach
tumors in the control animals treated with DW in the promotion
phase for 3 or 6 months was similar (Table IV). Although tumors
were not observed in male mice at 3 months, a yield of 1.5
papillomas was observed in 27% of females. However at 6 months,
the tumor rate and yield was comparable in animals of both sexes.
The cumulative rate of tumor development and yield increased
in a dose-dependent manner in animals given 12.5- or 25-mg doses
of EPME for 3 or 6 months. At the 50-mg dose the tumor rate at 3
months was similar to that in animals receiving 25 mg EPME,
while a significant reduction was noted in the 6-month-treatment
group (34% vs. 67%, p , 0.05). In male mice treated for 3 months
with different doses of EPME, the tumor rate and yield was higher
than those in the control group. Moreover, a significant elevation in
tumor incidence and yield (50% vs. 27%, 2.6 vs. 1.5 papillomas/
tumor bearer) was recorded in females treated with the 25-mg dose
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(Table IV). As compared with controls, promotion with 12.5- and
25-mg doses of EPME for 6 months increased the tumor rate and yield
in animals of both sexes, with maximum tumor incidence and rate (82%,
2.8 papillomas/tumor bearer) occurring in females treated with 25 mg
EPME.At the 50-mg dose, although the tumor rate declined, the number
of papillomas per tumor bearer was similar to that observed in animals
receiving the 2 lower doses of EPME.
Esophageal tumors. As shown in Table V, administration of DW
following DEN initiation for 3 or 6 months to control mice resulted
in overall tumor development in 4 and 11% of the animals, the
tumor yield being 1.0 and 1.7 respectively. Male mice treated with
DW for 3 months did not develop any tumors, while a single tumor
was observed in one female. At 6 months, although the tumor
incidence was similar in mice of both sexes, the tumor yield was
higher in males.
The total tumor rate and yield increased in a dose-dependent
manner in animals treated with different doses of EPME for 3 or 6
months. The increase was statistically significant in mice treated
TABLE III – SKIN-TUMOR-PROMOTING ACTIVITY OF EPME IN DMBA-INITIATED S/RVCri-ba MICE
Promoter Time when 1st tumor
visible (weeks)
Tumor development at
Week 20 Week 30 Week 40
Yield Rate Yield Rate Yield Rate
Acetone 18 0.1 6 0.05 10 2.1 6 0.5 80 4.2 6 1.0 100
EPME
12.5 mg 18 0.1 6 0.05 7 3.1 6 0.6 93 5.2 6 1.2 100
25 mg 20 0.1 6 0.1 13 3.4 6 0.6 100 6.8 6 0.7* 100
50 mg 18 0.9 6 0.2 56 2.8 6 0.3 100 5.7 6 0.7 100
The yield is the average number of papillomas per mouse; the rate is the percentage of tumor bearers.
*p , 0.05.
FIGURE 1 – Dose-response relationship in female S/RVCri-ba mice initiated with 20 nmol DMBA and treated with 12.5, 25 and 50 mg EPME
for 40 weeks. (a) Tumor rate, the percentage of tumor bearers. (b) Tumor yield, the average number of papillomas per mouse.
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with 25 mg EPME (Table V). Esophageal tumors were not
observed in male mice treated with 12.5 mg EPME for 3 months,
while a solitary tumor was recorded in a female. The tumor rate and
yield was similar in male and female mice treated with 25 or 50 mg
EPME. Six months after promotion with different doses of EPME,
a statistically insignificant increase in the percentage of tumor
bearers was observed in males and females as compared to
controls, while the tumor yield was similar in the control and the
experimental groups.
Tumor promotion with TPA. In these experiments, 5 nmol TPA
was administered by gavage as a positive control for 3 months. Due
to retardation in body weight, promotion was not continued
thereafter. Promotion with TPA significantly increased the cumula-
tive yield and proportion of mice with forestomach and esophageal
tumors (Tables IV, V). Moreover, the incidence of forestomach
tumors was similar in male and female mice, while the percentage
of animals with esophageal papillomas was significantly elevated
in females (Table V).
Histopathological observations. Mild hyperplasia of the forestom-
ach epithelium was observed in 20% and 35% of uninitiated or
DEN-initiated mice receiving 25 mg of EPME respectively. Mild
chronic inflammation indicative of esophagitis, as well as dyskera-
toma, a warty lesion with a crateriform appearance characterized
by keratinized and acantholytic cells (Fig. 2), were observed
infrequently in mice treated with 50 mg EPME. Papilloma (Fig. 3)
in both organs consisted of a localized exophytic excrescence lined
by squamous epithelium of varying number of cell layers and
increased keratinization, overlying a well-vascularized stroma.
Carcinoma was not necessarily associated with a papilloma, but
showed clear infiltration at the base of the lesion (Fig. 4). The
maximum incidence of carcinoma in the forestomach (10%) and
esophagus (7%) was observed at the 50-mg EPME dose. Other
histopathological observations revealed fatty and dysplastic changes,
and hemangioma in the liver in the experimental groups.
DISCUSSION
Pan masala is a complex mixture of various components whose
mutagenic and genotoxic properties have been demonstrated in
several short-term assays (IARC, 1985; Adhvaryu et al., 1989;
TABLE IV – INCIDENCE AND MULTIPLICITY OF TUMORS IN THE FORESTOMACH OF DEN-INITIATED ICRC MICE
TREATED WITH EPME
Promoter Sex
Duration
3 months 6 months
Number of
effective
animals
Tumor
bearers
(%)
Mean number of
tumors/tumor
bearer 6 S.E.
Number of
effective
animals
Tumor
bearers
(%)
Mean number of
tumors/tumor
bearer 6 S.E.
DW M 14 0 0 14 14 1.5 6 0.5
F 15 27 1.5 6 0.3 13 24 1.3 6 0.3
Total 29 14 1.5 6 0.3 27 19 1.4 6 0.3
EPME
12.5 mg M 15 26* 1.4 6 0.3 15 34 1.7 6 0.2
F 15 15 2.7 6 0.3** 15 37 2.5 6 0.2
Total 30 21 2.0 6 0.3 30 35 2.1 6 0.2
25 mg M 13 23 2.0 6 0.6 13 53* 1.7 6 0.3
F 14 50* 2.6 6 0.2** 13 82** 2.8 6 0.3*
Total 27 39* 2.2 6 0.2 26 67*** 2.4 6 0.3*
50 mg M 15 53** 1.2 6 0.1 15 13 2.0 6 0.0
F 15 27 1.5 6 0.3 14 57 2.6 6 0.3*
Total 30 40* 1.3 6 0.1 29 34 2.5 6 0.2*
TPA M 14 43** 2.7 6 0.2
5 nmol F 14 43 2.7 6 0.3
Total 28 43** 2.7 6 0.2**
*p , 0.05; **p , 0.01; ***p , 0.001.
TABLE V – INCIDENCE AND MULTIPLICITY OF TUMORS IN THE ESOPHAGUS OF DEN-INITIATED ICRC MICE
TREATED WITH EPME
Promoter Sex
Duration
3 months 6 months
Number of
effective
animals
Tumor
bearers
(%)
Mean number of
tumors/tumor
bearer 6 S.E.
Number of
effective
animals
Tumor
bearers
(%)
Mean number of
tumors/tumor
bearer 6 S.E.
DW M 14 0 0 14 14 2.0 6 0.0
F 15 7 1.0 6 0.0 13 9 1.0 6 0.0
Total 29 4 1.0 6 0.0 27 11 1.7 6 0.3
EPME
12.5 mg M 15 0 0 15 29 1.4 6 0.3
F 15 7 1.0 6 0.0 15 13 1.0 6 0.0
Total 30 3 1.0 6 0.0 30 21 1.3 6 0.2
25 mg M 13 15 1.5 6 0.5 13 47 2.3 6 0.5
F 14 23 1.3 6 0.3 13 41 1.8 6 0.3
Total 27 19* 1.4 6 0.2* 26 44** 2.1 6 0.3
50 mg M 15 13 1.0 6 0.0 15 27 1.5 6 0.3
F 15 20 2.2 6 0.7 14 43 1.5 6 0.3
Total 30 17 1.8 6 0.5 29 34 1.5 6 0.2
TPA M 14 7 2.0 6 0.0
5 nmol F 14 36* 1.4 6 0.2
Total 28 21* 1.5 6 0.2*
*p , 0.05; **p , 0.01.
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Bagwe et al., 1990; Mukherjee and Giri, 1991). Increased cytoge-
netic damage has been reported in peripheral-blood lymphocytes
and exfoliated buccal mucosa of pan-masala consumers (Dave et
al., 1991). However, the implications of habitual pan-masala use
with reference to cancer risk have not been fully evaluated by
epidemiological or experimental studies. Unlike tobacco chewers,
who spit out the juice, pan-masala users often swallow the liquid
extract. This increases the possibility of severe carcinogenic effects
of pan masala at sites other than the oral cavity. In addition to the
mouse-skin model of carcinogenesis, the forestomach and esopha-
gus serve as model systems wherein papillomas appear in response
to carcinogen initiation and promotion with croton oil or phorbol
ester (Goerttler et al., 1979). Hence in the present investigation,
complete carcinogenic, tumor-initiating, tumor-promoting as well
as progressor activities of pan masala were evaluated using Bare
mouse skin and esophagus, and forestomach of ICRC mice, as the
target organs. S/RVCri-ba or ‘‘Bare’’ mice are highly useful for
mechanistic studies on skin carcinogenesis (Bhisey and Veturkar,
1990), while the ICRC mouse strain is known to be susceptible to
the development of esophageal tumors, due to the presence of
hyperplastic mega-esophagus and achalasia or constriction at the
gastro-esophageal junction (Randelia et al., 1988; Ghaisas et al.,
1989).
Administration of pan masala to Swiss albino mice in the dose
range of 0.5 to 2 g/kg body weight is reported to be toxic, while the
lower dose range of 8 to 200 mg/kg body weight was found to
cause cytogenetic damage in bone-marrow cells, as well as
sperm-head abnormalities (Mukherjee et al., 1991). In the present
study, the dose range was selected to include the dose of 25 mg
EPME shown to elicit mutagenicity in the Ames assay (Bagwe et
al., 1990). EPME at doses of 25 or 50 mg/mouse was inactive as a
complete carcinogen or a tumor initiator in S/RVCri-ba mouse
skin. However, EPME exhibited mild skin-tumor-promoting activ-
ity requiring 30 to 40 weeks of treatment for eliciting a significant
increase in tumor yield. Experimental studies have shown that
while few papillomas progress to carcinomas by TPA promotion,
an increase in the appearance of carcinomas on treatment of
papilloma-bearing mice with initiating carcinogens can be attrib-
uted to an additional mutational event(s) occurring in the target cell
(Hennings et al., 1983). Thus, a 2-fold increase in the rate of
conversion of papilloma to carcinoma by application of EPME in
the progression phase observed in this study may be related to its
mutagenic potential (Bagwe et al., 1990).
Induction of sustained epidermal hyperplasia, inflammation and
increased cell proliferation are closely linked to the tumor-
promoting activity of many compounds (Argyris, 1985). Mild to
moderate loss of nuclear polarity, increase in keratoses and mitotic
figures, inflammatory cell infiltration, and edema, were observed
upon application of pan-masala paste to the oral mucosa of albino
rats (Khrime et al., 1991). An extract of betel-quid constituents
which contains the main pan-masala ingredients was found to
stimulate cell proliferation and induce DNA-strand-break forma-
tion in oral mucosal fibroblasts in vitro (Jeng et al., 1994). A
decrease in the number of basal cells and an increase in suprabasal
mitotic cells observed in EPME-treated epidermis in this study
were similar to that reported in TPA-treated mouse skin (Astrup
and Iversen, 1981; Argyris, 1985). Moreover, an increased rate of
epidermal and dermal DNA synthesis, mitotic activity and induc-
tion of mild but sustained epidermal hyperplasia and dermal edema
by a single or multiple applications of EPME correlated well with
its tumor-promoting potential.
Upper gastrointestinal lesions and oral submucous fibrosis are
known to be associated with high risk for cancer development in
those addicted to chewing of betel quid with or without tobacco
(Jussawalla, 1981; Sinor et al., 1990; Anuradha and Devi, 1993;
FIGURE 2 – Warty dyskeratoma of esophagus. The lesion shows a
crateriform appearance with acantholytic papillae in the center (inset)
and abnormal single-cell keratinization. Scale bar, 250 µm.
FIGURE 3 – Papilloma. The lesion consists of keratinizing exophytic
processes of a squamous nature forming an elevated nodule in
forestomach mucosa. Scale bar, 125 µm.
FIGURE 4 – Carcinoma. Sheets of focally keratinizing invasive
squamous carcinoma are noted. Scale bar, 50 µm.
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Ahmed et al., 1993). Betel-quid ingredients, when administered
separately or in various combinations to Syrian hamsters, have
been shown to induce gastric and buccal-pouch tumors (Ranadive
et al., 1979). In the present study, administration of EPME to
DEN-initiated ICRC mice significantly enhanced, in a concentration-
dependent manner, the development of papillomas in the forestom-
ach and esophagus for up to 25 mg EPME. The gastric- and
esophageal-tumor-promoting activity exhibited by EPME at the 25
mg dose, was comparable with that observed with the potent tumor
promoter, TPA, although EPME promoted papilloma development
in the forestomach to a greater extent than in the esophagus.
Additionally, the induction of squamous-cell carcinomas in the
forestomach and esophagus of EPME-treated mice indicates that
pan masala may influence the progression of malignant tumors.
Generally, female mice appeared to be more susceptible than males
to the development of papilloma and carcinoma in both organs.
These observations are interesting in view of the fact that a high
incidence of upper-alimentary-tract cancers was observed in Indian
females in South Africa who habitually chewed betel quid (Oettle,
1967; Schonland and Bradshaw, 1969).
Although the precise nature of the carcinogenic/co-carcinogenic
effects of pan masala in both the mouse models is not known, there
are several possibilities. Chemical toxicological evaluation of pan
masala has revealed the presence of polyaromatic hydrocarbons,
nitrosamines, toxic metals such as lead, cadmium and nickel, and
residual pesticides (Kashyap et al., 1989). Areca nut, the main
component of pan masala, contains several alkaloids which are
converted to carcinogenic nitrosamines in mild nitrosation condi-
tions (Nair et al., 1985). Arecaidine and its methyl ester, arecoline
have been suspected of exhibiting carcinogenic/mutagenic proper-
ties, since they are capable of reacting with cysteine in vivo and in
vitro to produce cysteine/3-alkylation adducts (Boyland and Nery,
1969). In addition, reactive oxygen species, which are implicated in
the multistep process of carcinogenesis, may be generated during
the extraction of pan masala, due to auto-oxidation of polyphenols
and interaction of catechin with lime (Nair et al., 1992). The
possibility of arecaidine being produced by hydrolysis of arecoline
in mild alkaline conditions during the extraction procedure cannot
be overlooked. Ethanol is reported to potentiate the clastogenicity
of pan masala in Chinese hamster ovary cells (Patel et al., 1994).
However, whether the small amount of ethanol used in this study
for solubilizing the dry extract of pan masala can contribute to its
carcinogenicity needs to be investigated. Thus it is reasonable to
assume that some of these compounds, as well as tannins in catechu
(IARC, 1985), may be responsible for the carcinogenic and
tumor-promoting properties of pan masala observed in the present
study. More importantly, the findings on increased induction of
benign and malignant tumors in all 3 target organs suggests that
pan-masala use may exert carcinogenic as well as co-carcinogenic
influence in habitual users of this product.
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